motessanib

motessanib (aeye. aim. jee. 706) ack prayogaatmak dawa haye jise mool roop seey amgen dwara vikasit kiya gayaa thaa, lekin baad mein isaki jaanch takeda dawa company dwara kii gaee. yeh angiokinez avarodhak varg seey sambandhit ack maukhik roop seey prashaasit chhota anu haye joe ways receptors, platelet-vyutpann vikas kaarak receptors aur stame cell kaarak receptors key virodhi key roop mein kaary kartaa haye. iska upayog phosphat namak motessanib diphosphate key roop mein kiya jaataa haye. thyroid cancer, gair-chhoti koshika fefde key cancer, gastroentestinal stromal cancer, colorectal cancer aur stun cancer mein naidaanik parikshanon key baad, dawa aage key vikas key liye paryaapt prabhavkarita naheen dikhaati thee, aur vikas koo tekeda dwara chhod diyaa gayaa thaa.
naidaanik pareekshan.
motessanib kii mool roop seey unnat gair-squamous gair-chhoti-koshika fefde key cancer (aine. aiss. see. ell. see.) key khilaf prabhavsheelta key liye jaanch kii gaee thee, jisamen charan II parikshanon seey pataa chalata haye kii bevaisizumab kii tulanaa mein prabhavsheelta haye jaba donon kaa upayog paclitexel/carboplatin key sanyojan mein kiya gayaa thaa. halanki baad mein aur adhik vistrit charan III pareekshan aine. aiss. see. ell. see. key upchaar key liye koee laabh dikhaane mein whiffle rhaa. 2012 mein doosara charan III pareekshan shuru kiya gayaa thaa, joe asiai prishthabhoomi key rogiyon parr kendrit thaa (upsamooh vishleshan key aadhar parr kiya gayaa) lekin yeh bhee apane praathamik antim bindu parr pahunchane mein whiffle rhaa.
stun cancer key liye pahali pankti kii chikitsa key roop mein dawa kaa charan II mulyankan kiya gayaa haye, halanki iss adhyayan mein aage kii jaanch kaa samarthan karane key liye koee saboot naheen milaa haye. lagaatar yaa baar-baar honey vaale dimbagranthi, phalopian tube aur praathamik peritoneal carcinoma key khilaf charan II pareekshan bhee asafal rhaa. thyroid cancer key liye dou charan II naidaanik parikshanon ney ashajanak parinam dikhaae.

